GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZXF) » Definitions » Other Income (Expense)

SDZXF (Sandoz Group AG) Other Income (Expense) : $-88 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Other Income (Expense)?

Sandoz Group AG's other income expense for the Sandoz Group AG's pretax income for the six months ended in Dec. 2024 was $-88 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-88 Mil.

Sandoz Group AG Other Income (Expense) Historical Data

The historical data trend for Sandoz Group AG's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Other Income (Expense) Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24
Other Income (Expense)
-50.00 -71.00 -88.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
Other Income (Expense) - - -71.00 - -88.00

Sandoz Group AG Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG  (OTCPK:SDZXF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Sandoz Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZXF) » Definitions » Other Income (Expense)
Comparable Companies
XSWX:GALD XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA NSE:DIVISLAB HKSE:03692 SZSE:000538 BOM:500087 ITCI VTRS TSE:4507 NBIX NSE:TORNTPHARM SHSE:688506
Traded in Other Exchanges
SDZNY:USA SDZz:UK 0SAN:UK D8Y0:Germany SDZ:Switzerland
Address
Centralbahnstrasse 4, Basel, CHE, 4051
Website
https://www.sandoz.com
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in its pipeline.